title: Serum prolactin in symptomatic and asymptomatic dopa-responsive dystonia due to a GCH1 mutation.
authors.affiliation: Movement Disorders Research Laboratory, Centre for Addiction and Mental Health-Clarke Division, Toronto, Ontario, Canada. Yoshiaki_Furukawa@camh.net
authors.forename: Y
authors.initials: Y
authors.lastname: Furukawa
authors.forename: M
authors.initials: M
authors.lastname: Guttman
authors.forename: H
authors.initials: H
authors.lastname: Wong
authors.forename: S A
authors.initials: SA
authors.lastname: Farrell
authors.forename: S
authors.initials: S
authors.lastname: Furtado
authors.forename: S J
authors.initials: SJ
authors.lastname: Kish
mesh_terms: D019943:Amino Acid Substitution; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D020821:Dystonic Disorders / Q000097:blood / Q000188:drug therapy / Q000235:genetics*; D005091:Exons / Q000235:genetics; D005260:Female; D006136:GTP Cyclohydrolase / Q000172:deficiency / Q000235:genetics*; D005799:Genes, Dominant; D006579:Heterozygote; D006801:Humans; D008297:Male; D020125:Mutation, Missense; D010375:Pedigree; D017354:Point Mutation; D011388:Prolactin / Q000097:blood*
chemical_list: D004295:Dihydroxyphenylalanine; D011388:Prolactin; D006136:GTP Cyclohydrolase